Shea J J, Emmett J R, Harell M
Laryngoscope. 1977 Nov;87(11):1809-14. doi: 10.1002/lary.1977.87.11.1809.
Thirty patients with sudden hearing loss were treated with diatrizoate meglumine (Hypaque) and a vasodilator regimen. Of these patients, 30% had a good response, 23% had a moderate response, and 47% had no response. These results were superior to the results obtained in a group of patients with sudden hearing loss treated with vasodilators alone. A possible mode of action is discussed and the details of a new study outlined.
30例突发性听力损失患者接受了泛影葡胺（Hypaque）和血管扩张剂治疗方案。在这些患者中，30%有良好反应，23%有中度反应，47%无反应。这些结果优于一组仅接受血管扩张剂治疗的突发性听力损失患者的结果。讨论了一种可能的作用方式，并概述了一项新研究的细节。
